Detalhe da pesquisa
1.
Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL.
Blood
; 126(18): 2110-7, 2015 Oct 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26316624
2.
Correction: Jamal et al. Preparation of 6-Mercaptopurine Loaded Liposomal Formulation for Enhanced Cytotoxic Response in Cancer Cells. Nanomaterials 2022, 12, 4029.
Nanomaterials (Basel)
; 14(5)2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38470810
3.
Application of Newly Customized Myeloid NGS Panel in the Diagnosis of Myeloid Malignancies.
Int J Gen Med
; 17: 37-48, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38204493
4.
Preparation of 6-Mercaptopurine Loaded Liposomal Formulation for Enhanced Cytotoxic Response in Cancer Cells.
Nanomaterials (Basel)
; 12(22)2022 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36432314
5.
Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features.
Nat Genet
; 54(11): 1675-1689, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36333502
6.
Clinical application of targeted and genome-wide technologies: can we predict treatment responses in chronic lymphocytic leukemia?
Per Med
; 10(4): 361-376, 2013 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24611071